Core Viewpoint - The increasing prevalence of myopia among adolescents has become a global public health challenge, necessitating long-term prevention strategies integrated into daily life, including lifestyle habits, eye behavior, and regular check-ups [1] Group 1: Myopia Prevention Strategies - Myopia prevention must shift focus to preschool children under 6 years old due to insufficient hyperopia reserves in school-age children [2] - Children can be categorized based on their hyperopia reserves into three groups for differentiated management: sufficient, relatively insufficient, and pre-myopic [2] Group 2: Recommendations for Different Categories - For children with sufficient hyperopia reserves (not lower than recommended values), measures include encouraging outdoor activities, cultivating good eye habits, and optimizing visual environments, with follow-up monitoring every 6-12 months [4] - For children with relatively insufficient hyperopia reserves (greater than 0.75D but below recommended values), stronger interventions are advised, such as increasing outdoor activities and reducing near work, with follow-up every 3-6 months [5] - For pre-myopic children with low hyperopia reserves, intervention effects may be limited, but low-concentration atropine treatment is recommended for those below +1.00D, and combined optical methods for those with a family history of myopia [6][7] Group 3: Daily Prevention Practices - Adopting scientific eye care methods and maintaining them over time is more effective than temporary measures, with the "20-20-20" rule being a practical approach [9] - Daily outdoor activity of over 2 hours is essential for healthy eye development, and regular vision checks every 6 months are recommended for myopic adolescents [9] - A diet rich in dark fruits and vegetables, which contain carotenoids, can help protect the eyes, while limiting sugar intake is crucial as higher consumption correlates with increased myopia rates [9] Group 4: Long-term Commitment to Eye Health - Myopia prevention requires a comprehensive understanding of its causes, proper lens fitting, consistent eye care, healthy eating, and regular monitoring, all contributing to a protective network for children's vision [10]

Group 1 - The article discusses the increasing interest in myopia correction methods due to factors like job applications and aesthetic improvements, highlighting the popularity of topics like "myopia correction surgery" [1] - Myopia correction surgery, including laser procedures and artificial lens implantation, is a mature method for vision correction, but it is not a permanent solution; proper eye care post-surgery is essential [1] - The "20-20" rule is recommended for alleviating eye fatigue caused by prolonged screen time, suggesting a break every 20 minutes of close work by looking at something 20 feet away for 20 seconds [1] Group 2 - There is currently no clear medical evidence supporting the effectiveness of various eye care products like "myopia prevention patches" and "eye care devices," and their use is not recommended without verified methods [2] - Effective myopia prevention strategies include at least 2 hours of outdoor activity daily, using optical aids like OK lenses under medical guidance, and following prescriptions for low-concentration atropine [2] - The misconception that myopic individuals do not experience presbyopia is addressed; both conditions can coexist as they arise from different causes [2] Group 3 - It is advised that middle-aged individuals should regularly update their reading glasses as the prescription may change with age, and failing to do so can lead to eye strain and potential vision deterioration [4] - Symptoms like blurred vision, double vision, and headaches may indicate serious eye conditions such as cataracts or glaucoma, necessitating prompt medical attention [4]

Core Viewpoint - The article discusses the limitations of myopia correction surgeries and emphasizes the importance of proper eye care practices post-surgery, as well as addressing common misconceptions about myopia and presbyopia. Group 1: Myopia Correction Surgeries - Myopia correction surgeries, including laser procedures and artificial lens implantation, are effective but not a permanent solution, as prolonged near work can lead to fluctuations in vision [1] - Proper eye care practices, such as maintaining a regular schedule and using eyes scientifically, are crucial for protecting vision after surgery [1] Group 2: Eye Care Products and Practices - Current eye care products like "myopia prevention patches" and "eye care devices" lack clear medical evidence supporting their effectiveness, and their use is not recommended without proper validation [2] - Effective myopia prevention methods include at least 2 hours of outdoor activity daily, wearing OK lenses or functional glasses under medical guidance, and using low-concentration atropine as prescribed [2] Group 3: Myopia and Presbyopia Misconceptions - Myopia and presbyopia have different causes and do not counteract each other; individuals with myopia may experience both conditions as they age [2] - Older adults should regularly update their presbyopic glasses, as the prescription may change with age, and using outdated prescriptions can lead to eye fatigue and potentially accelerate vision decline [2][3] Group 4: Eye Health Monitoring - Symptoms such as blurred vision, double vision, and headaches may indicate serious eye conditions like cataracts or glaucoma, necessitating prompt medical attention [3] - Regular eye examinations are recommended, especially for individuals with hypertension, diabetes, or a family history of eye diseases, ideally every six months to a year [3]

Core Viewpoint - The perception that myopia surgery completely eliminates myopia and prevents regression is incomplete, as myopia cannot be cured, and new myopia may develop if eye care is neglected [1][2] Group 1: Myopia Surgery Insights - Myopia surgery can help individuals become independent from glasses, with techniques such as corneal laser surgery (e.g., SMILE Pro) and intraocular lens surgery (e.g., ICL, V4C, V5) effectively improving vision [1] - Post-surgery, it is crucial to maintain long-term eye care, as improper habits like excessive screen time or rubbing the eyes can still negatively impact vision [1] Group 2: Vision Protection Recommendations - To protect vision, maintaining a regular schedule and avoiding prolonged screen time is essential, with the "20-20" rule recommended: take a 20-second break every 20 minutes of screen time, ideally looking at something 5 meters away [2] - There is currently no medical evidence supporting the effectiveness of myopia prevention patches or devices, and validated methods should be prioritized for myopia control [2] - Recommended strategies for myopia prevention include at least 2 hours of outdoor activity daily, using optical aids like OK lenses or prescription glasses under medical guidance, and considering low-concentration atropine under a doctor's advice [2]

Core Viewpoint - The effectiveness of products claiming to prevent myopia and improve vision, such as "myopia prevention patches" and "eye protection devices," lacks medical evidence and is not recommended by experts [1] Group 1: Expert Opinions - Dr. Zhou Xingtao from Fudan University emphasizes that there is currently no medical evidence supporting the effectiveness of these products, highlighting that myopia cannot be cured once it occurs [1] - The focus should be on validated methods for myopia prevention, rather than unproven products [1] Group 2: Recommended Prevention Methods - The first recommended method is lifestyle changes, specifically engaging in at least 2 hours of outdoor activities daily, with a minimum of 1 hour being effective for children who struggle to meet the full 2 hours [1] - The second method involves optical solutions, including OK lenses and certain functional glasses, which should be used under medical guidance [1] - The third method includes pharmacological options, such as low-concentration atropine, which must also be used according to a doctor's advice [1]

Core Insights - The rapid increase in myopia among adolescents is a significant concern, with various preventive measures recommended by experts [2][3] - Emphasis on controlling screen time and promoting outdoor activities as effective strategies to mitigate myopia risk [2][3] Group 1: Preventive Measures - Controlling eye usage time, especially for prolonged and close-range activities, is crucial for myopia prevention [2] - Increasing outdoor activities is highlighted as one of the most economical and effective measures for eye relaxation and myopia prevention [2] - Developing good eye habits, including proper posture and reading techniques, is essential for controlling myopia [2] Group 2: Lifestyle Recommendations - A balanced diet, sufficient sleep, and regular eye examinations are also important components of myopia prevention [2] - Monitoring close-range and prolonged eye usage, along with scientific eye care practices, is key to managing myopia risk [2] Group 3: Electronic Device Usage - Despite the presence of eye protection features in modern electronic devices, they do not completely alleviate the strain on eyes or the risk of myopia [3] - Strict control of electronic device usage time is recommended for young children, with specific limits set for different age groups [3] - Comprehensive preventive measures, including the use of OK lenses, low-concentration atropine eye drops, and functional glasses, can help manage myopia progression [3]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to experience rapid growth in 2025, particularly with the anticipated increase in sales of low-concentration atropine [3][4] - In 2024, the company reported a revenue of 1.943 billion yuan, representing a year-on-year increase of 32.42%, and a net profit attributable to shareholders of 338 million yuan, up 40.84% [3][4] - The company is positioned as a leader in the myopia prevention medication sector, with a strong focus on the promotion of its core product, low-concentration atropine [3][4] Financial Summary - The company's revenue is projected to grow from 1.943 billion yuan in 2024 to 2.948 billion yuan in 2025, reflecting a year-on-year growth rate of 51.7% [6] - The net profit attributable to shareholders is expected to increase significantly from 338 million yuan in 2024 to 688 million yuan in 2025, marking a growth of 103.6% [6] - The gross margin is forecasted to improve from 78.3% in 2024 to 80.6% in 2025, while the net margin is expected to rise from 17.4% to 23.3% during the same period [6] Product Development - The company has developed a series of ophthalmic products, including the first approved cyclosporine eye drops for dry eye syndrome in China, which generated sales of 298 million yuan in 2023 [4] - The approval of sulfate atropine eye drops in March 2024 is expected to enhance the company's product lineup and meet the growing demand for myopia treatment among children and adolescents [4] - The revenue from eye drops is projected to reach 1.366 billion yuan in 2024, with a remarkable growth rate of 106.08% [4]

Summary of Conference Call Company Overview - The conference call involved the management team of Zhaoke Ophthalmology, including Dr. Li Xiaoyi (Chairman and CEO), Dai Xiangrong (COO), and Irene Cho (Company Secretary and CFO) [1] Key Highlights Financial Performance - Revenue growth of approximately 200% to 270% compared to 2023, indicating significant financial improvement [2] - The company maintains a strong cash position, with sufficient cash reserves expected to last until the end of 2024 [2] Research and Development (R&D) - Significant progress in R&D, with three key products entering substantive review processes [3] - Successful completion of Phase III clinical trials for TKB014, with preparations for NDA submission underway [3] - Initiation of Phase II clinical trials for presbyopia treatment, with the first patient enrolled [3] Product Pipeline - The company has a comprehensive glaucoma product lineup, with all six different prostaglandin glaucoma medications approved for market [4] - Focus on commercializing products and optimizing the commercialization team to prepare for future launches [4] Market Expansion - The company is actively pursuing international markets, particularly in the Asia-Pacific region, with successful product launches in Australia and New Zealand [27] - Plans to expand product offerings in various regions, including Southeast Asia [27] Commercialization Strategy - A robust sales team has been established, focusing on ophthalmology with over 20 years of experience in the field [22] - The strategy includes building an ecosystem for ophthalmology channels, covering both public and private hospitals, as well as online sales [23][25] - Collaboration with leading companies to enhance market access and resource integration [25] Future Outlook - The company aims for a significant leap in development by 2026, with a focus on launching key products [5] - Preparations for commercializing products are ongoing, with expectations for more milestones in 2025 [35] Additional Insights - The company is committed to maintaining a strong focus on product quality and regulatory compliance, with ongoing communication with regulatory bodies [39][46] - The management emphasizes that the company's stock price is ultimately tied to business performance and product success, rather than short-term market fluctuations [39] Conclusion - Zhaoke Ophthalmology is positioned for growth with a strong product pipeline, effective commercialization strategies, and a commitment to expanding into international markets. The management is optimistic about achieving significant milestones in the coming years [54]